目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Application
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Solution
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 12: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 13: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 14: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibit 15: Data Table on US: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Genomics market in US 2017 - 2021
Exhibit 16: Historic Market Size - Data Table on genomics market in US 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 17: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 18: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Solution Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Solution Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application
6.1 Market segments
Exhibit 27: Chart on Application - Market share 2022-2027 (%)
Exhibit 28: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 29: Chart on Comparison by Application
Exhibit 30: Data Table on Comparison by Application
6.3 Diagnostic - Market size and forecast 2022-2027
Exhibit 31: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibit 32: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibit 33: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibit 34: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
6.4 Drug discovery - Market size and forecast 2022-2027
Exhibit 35: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibit 37: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibit 38: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 39: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 41: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 42: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Application
Exhibit 43: Market opportunity by Application ($ million)
Exhibit 44: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 45: Chart on End-user - Market share 2022-2027 (%)
Exhibit 46: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 47: Chart on Comparison by End-user
Exhibit 48: Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2022-2027
Exhibit 49: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 52: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
7.4 Academic and research institutes - Market size and forecast 2022-2027
Exhibit 53: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 55: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 56: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
7.5 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
Exhibit 57: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 59: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibit 60: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 61: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by End-user
Exhibit 65: Market opportunity by End-user ($ million)
Exhibit 66: Data Table on Market opportunity by End-user ($ million)

8 Market Segmentation by Solution
8.1 Market segments
Exhibit 67: Chart on Solution - Market share 2022-2027 (%)
Exhibit 68: Data Table on Solution - Market share 2022-2027 (%)
8.2 Comparison by Solution
Exhibit 69: Chart on Comparison by Solution
Exhibit 70: Data Table on Comparison by Solution
8.3 Products - Market size and forecast 2022-2027
Exhibit 71: Chart on Products - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Products - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Products - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Products - Year-over-year growth 2022-2027 (%)
8.4 Services - Market size and forecast 2022-2027
Exhibit 75: Chart on Services - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Services - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Services - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Services - Year-over-year growth 2022-2027 (%)
8.5 Market opportunity by Solution
Exhibit 79: Market opportunity by Solution ($ million)
Exhibit 80: Data Table on Market opportunity by Solution ($ million)

9 Customer Landscape
9.1 Customer landscape overview
Exhibit 81: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 82: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 83: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 84: Overview on factors of disruption
11.4 Industry risks
Exhibit 85: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 86: Vendors covered
12.2 Market positioning of vendors
Exhibit 87: Matrix on vendor position and classification
12.3 Agilent Technologies Inc.
Exhibit 88: Agilent Technologies Inc. - Overview
Exhibit 89: Agilent Technologies Inc. - Business segments
Exhibit 90: Agilent Technologies Inc. - Key offerings
Exhibit 91: Agilent Technologies Inc. - Segment focus
12.4 BGI Genomics Co. Ltd.
Exhibit 92: BGI Genomics Co. Ltd. - Overview
Exhibit 93: BGI Genomics Co. Ltd. - Product / Service
Exhibit 94: BGI Genomics Co. Ltd. - Key offerings
12.5 Bio Rad Laboratories Inc.
Exhibit 95: Bio Rad Laboratories Inc. - Overview
Exhibit 96: Bio Rad Laboratories Inc. - Business segments
Exhibit 97: Bio Rad Laboratories Inc. - Key news
Exhibit 98: Bio Rad Laboratories Inc. - Key offerings
Exhibit 99: Bio Rad Laboratories Inc. - Segment focus
12.6 Color Health Inc.
Exhibit 100: Color Health Inc. - Overview
Exhibit 101: Color Health Inc. - Product / Service
Exhibit 102: Color Health Inc. - Key offerings
12.7 Danaher Corp.
Exhibit 103: Danaher Corp. - Overview
Exhibit 104: Danaher Corp. - Business segments
Exhibit 105: Danaher Corp. - Key news
Exhibit 106: Danaher Corp. - Key offerings
Exhibit 107: Danaher Corp. - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 108: F. Hoffmann La Roche Ltd. - Overview
Exhibit 109: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 110: F. Hoffmann La Roche Ltd. - Key news
Exhibit 111: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 112: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Illumina Inc.
Exhibit 113: Illumina Inc. - Overview
Exhibit 114: Illumina Inc. - Business segments
Exhibit 115: Illumina Inc. - Key news
Exhibit 116: Illumina Inc. - Key offerings
Exhibit 117: Illumina Inc. - Segment focus
12.10 LetsGetChecked
Exhibit 118: LetsGetChecked - Overview
Exhibit 119: LetsGetChecked - Product / Service
Exhibit 120: LetsGetChecked - Key offerings
12.11 Myriad Genetics Inc.
Exhibit 121: Myriad Genetics Inc. - Overview
Exhibit 122: Myriad Genetics Inc. - Product / Service
Exhibit 123: Myriad Genetics Inc. - Key offerings
12.12 Oxford Nanopore Technologies plc
Exhibit 124: Oxford Nanopore Technologies plc - Overview
Exhibit 125: Oxford Nanopore Technologies plc - Product / Service
Exhibit 126: Oxford Nanopore Technologies plc - Key offerings
12.13 Pacific Biosciences of California Inc.
Exhibit 127: Pacific Biosciences of California Inc. - Overview
Exhibit 128: Pacific Biosciences of California Inc. - Product / Service
Exhibit 129: Pacific Biosciences of California Inc. - Key offerings
12.14 PerkinElmer Inc.
Exhibit 130: PerkinElmer Inc. - Overview
Exhibit 131: PerkinElmer Inc. - Business segments
Exhibit 132: PerkinElmer Inc. - Key news
Exhibit 133: PerkinElmer Inc. - Key offerings
Exhibit 134: PerkinElmer Inc. - Segment focus
12.15 QIAGEN NV
Exhibit 135: QIAGEN NV - Overview
Exhibit 136: QIAGEN NV - Product / Service
Exhibit 137: QIAGEN NV - Key news
Exhibit 138: QIAGEN NV - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 139: Thermo Fisher Scientific Inc. - Overview
Exhibit 140: Thermo Fisher Scientific Inc. - Business segments
Exhibit 141: Thermo Fisher Scientific Inc. - Key news
Exhibit 142: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 143: Thermo Fisher Scientific Inc. - Segment focus
12.17 Twist Bioscience Corp.
Exhibit 144: Twist Bioscience Corp. - Overview
Exhibit 145: Twist Bioscience Corp. - Product / Service
Exhibit 146: Twist Bioscience Corp. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 147: Inclusions checklist
Exhibit 148: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 149: Currency conversion rates for US$
13.4 Research methodology
Exhibit 150: Research methodology
Exhibit 151: Validation techniques employed for market sizing
Exhibit 152: Information sources
13.5 List of abbreviations
Exhibit 153: List of abbreviations
product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Application
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Solution
Exhibits7: Executive Summary - Chart on Vendor Market Positioning
Exhibits8: Parent market
Exhibits9: Market Characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits13: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits14: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibits15: Data Table on US: Year-over-year growth 2022-2027 (%)
Exhibits16: Historic Market Size - Data Table on genomics market in US 2017 - 2021 ($ million)
Exhibits17: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits18: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
Exhibits20: Five forces analysis - Comparison between 2022 and 2027
Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits23: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits24: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits25: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits26: Chart on Market condition - Five forces 2022 and 2027
Exhibits27: Chart on Application - Market share 2022-2027 (%)
Exhibits28: Data Table on Application - Market share 2022-2027 (%)
Exhibits29: Chart on Comparison by Application
Exhibits30: Data Table on Comparison by Application
Exhibits31: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibits32: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibits33: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits34: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits35: Chart on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibits36: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ million)
Exhibits37: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits38: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits39: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits40: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits41: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits42: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits43: Market opportunity by Application ($ million)
Exhibits44: Data Table on Market opportunity by Application ($ million)
Exhibits45: Chart on End-user - Market share 2022-2027 (%)
Exhibits46: Data Table on End-user - Market share 2022-2027 (%)
Exhibits47: Chart on Comparison by End-user
Exhibits48: Data Table on Comparison by End-user
Exhibits49: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits50: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits51: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits52: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits53: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits54: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits55: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits56: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits57: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits58: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits59: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits60: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits61: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits65: Market opportunity by End-user ($ million)
Exhibits66: Data Table on Market opportunity by End-user ($ million)
Exhibits67: Chart on Solution - Market share 2022-2027 (%)
Exhibits68: Data Table on Solution - Market share 2022-2027 (%)
Exhibits69: Chart on Comparison by Solution
Exhibits70: Data Table on Comparison by Solution
Exhibits71: Chart on Products - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Products - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Products - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Products - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Services - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Services - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Services - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Services - Year-over-year growth 2022-2027 (%)
Exhibits79: Market opportunity by Solution ($ million)
Exhibits80: Data Table on Market opportunity by Solution ($ million)
Exhibits81: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits82: Impact of drivers and challenges in 2022 and 2027
Exhibits83: Overview on Criticality of inputs and Factors of differentiation
Exhibits84: Overview on factors of disruption
Exhibits85: Impact of key risks on business
Exhibits86: Vendors covered
Exhibits87: Matrix on vendor position and classification
Exhibits88: Agilent Technologies Inc. - Overview
Exhibits89: Agilent Technologies Inc. - Business segments
Exhibits90: Agilent Technologies Inc. - Key offerings
Exhibits91: Agilent Technologies Inc. - Segment focus
Exhibits92: BGI Genomics Co. Ltd. - Overview
Exhibits93: BGI Genomics Co. Ltd. - Product / Service
Exhibits94: BGI Genomics Co. Ltd. - Key offerings
Exhibits95: Bio Rad Laboratories Inc. - Overview
Exhibits96: Bio Rad Laboratories Inc. - Business segments
Exhibits97: Bio Rad Laboratories Inc. - Key news
Exhibits98: Bio Rad Laboratories Inc. - Key offerings
Exhibits99: Bio Rad Laboratories Inc. - Segment focus
Exhibits100: Color Health Inc. - Overview
Exhibits101: Color Health Inc. - Product / Service
Exhibits102: Color Health Inc. - Key offerings
Exhibits103: Danaher Corp. - Overview
Exhibits104: Danaher Corp. - Business segments
Exhibits105: Danaher Corp. - Key news
Exhibits106: Danaher Corp. - Key offerings
Exhibits107: Danaher Corp. - Segment focus
Exhibits108: F. Hoffmann La Roche Ltd. - Overview
Exhibits109: F. Hoffmann La Roche Ltd. - Business segments
Exhibits110: F. Hoffmann La Roche Ltd. - Key news
Exhibits111: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits112: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits113: Illumina Inc. - Overview
Exhibits114: Illumina Inc. - Business segments
Exhibits115: Illumina Inc. - Key news
Exhibits116: Illumina Inc. - Key offerings
Exhibits117: Illumina Inc. - Segment focus
Exhibits118: LetsGetChecked - Overview
Exhibits119: LetsGetChecked - Product / Service
Exhibits120: LetsGetChecked - Key offerings
Exhibits121: Myriad Genetics Inc. - Overview
Exhibits122: Myriad Genetics Inc. - Product / Service
Exhibits123: Myriad Genetics Inc. - Key offerings
Exhibits124: Oxford Nanopore Technologies plc - Overview
Exhibits125: Oxford Nanopore Technologies plc - Product / Service
Exhibits126: Oxford Nanopore Technologies plc - Key offerings
Exhibits127: Pacific Biosciences of California Inc. - Overview
Exhibits128: Pacific Biosciences of California Inc. - Product / Service
Exhibits129: Pacific Biosciences of California Inc. - Key offerings
Exhibits130: PerkinElmer Inc. - Overview
Exhibits131: PerkinElmer Inc. - Business segments
Exhibits132: PerkinElmer Inc. - Key news
Exhibits133: PerkinElmer Inc. - Key offerings
Exhibits134: PerkinElmer Inc. - Segment focus
Exhibits135: QIAGEN NV - Overview
Exhibits136: QIAGEN NV - Product / Service
Exhibits137: QIAGEN NV - Key news
Exhibits138: QIAGEN NV - Key offerings
Exhibits139: Thermo Fisher Scientific Inc. - Overview
Exhibits140: Thermo Fisher Scientific Inc. - Business segments
Exhibits141: Thermo Fisher Scientific Inc. - Key news
Exhibits142: Thermo Fisher Scientific Inc. - Key offerings
Exhibits143: Thermo Fisher Scientific Inc. - Segment focus
Exhibits144: Twist Bioscience Corp. - Overview
Exhibits145: Twist Bioscience Corp. - Product / Service
Exhibits146: Twist Bioscience Corp. - Key offerings
Exhibits147: Inclusions checklist
Exhibits148: Exclusions checklist
Exhibits149: Currency conversion rates for US$
Exhibits150: Research methodology
Exhibits151: Validation techniques employed for market sizing
Exhibits152: Information sources
Exhibits153: List of abbreviations